Similar increases observed for higher-order births; increase in mean age at first birth seen in all racial and ethnic groups.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

Pediatricians should provide their patients with their contraceptive of choice, if no medical contraindications exist.

A second case of acute liver failure resulting in death has been reported in nonambulatory DMD patients treated with Elevidys.

0.5 percent with obesity were prescribed an obesity medication in 2023; 83 percent of prescriptions received by teens with severe obesity ...

The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.